Jefferies Maintains “Buy” Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning

With important upside potential, Wave Life Sciences Ltd. (NASDAQ:WVE) secures a spot connected our database of the best small-cap biotech stocks to bargain according to analysts.

On November 13, 2025, Jefferies expert Roger Song noted that Wave Life Sciences Ltd. (NASDAQ:WVE)’s competitory positioning is improving, with Korro Bio’s KRRO-110 reporting nonaccomplishment to nutrient protective levels of corrected macromolecule successful a Phase 1/2 AATD trial. This led to the discontinuation of Korro Bio’s pb asset. The expert keeps a “Buy” standing with a $26 terms people connected Wave Life Sciences.

Meanwhile, Wave Life Sciences Ltd. (NASDAQ:WVE) reported its Q3 results connected November 10, 2025, wherever its $7.6 cardinal gross missed expert forecasts of $12.89 million. At the aforesaid time, the institution reduced its nett nonaccomplishment from $61.8 cardinal successful Q3 2024 to $53.9 million, contempt R&D and G&A expenses expanding to $45.9 cardinal and $18.1 million. Increased costs were related to the company’s ongoing concern successful objective programs, peculiarly the WVE-007 trial.

Furthermore, the 4th saw Wave Life Sciences Ltd. (NASDAQ:WVE) reporting a currency runway extended done Q2 2027. This volition assistance guarantee operational continuity and backing for ongoing objective and improvement initiatives. Looking ahead, the institution seems well-positioned to beforehand its clinical-stage pipeline, arsenic it remains focused connected RNA-based therapies and strategical enlargement of its merchandise improvement programs.

Wave Life Sciences Ltd. (NASDAQ:WVE), a clinical-stage biotech company, develops and commercializes ribonucleic acerb (RNA) medicines with the assistance of its proprietary PRISM find and cause improvement platform.

While we admit the imaginable of WVE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 7 Best Oil and Gas Penny Stocks to Buy According to Analysts and Billionaire Jacob Rothschild’s RIT Capital Partners: 9 Stocks with Huge Upside Potential.

Disclosure: None.